Medical Device News Magazine

Advarra Announces Appointment of Jonathan E. Shough as President, Technology Solutions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Advarra, the market leader in clinical research practice management technology, regulatory review solutions, and research quality and compliance consulting services, announced today that it has named Jonathan E. Shough to the position of President, Technology Solutions.

Shough brings over 30 years of experience in information technology, including more than 20 years in the clinical research industry. He will be a member of the executive leadership team, reporting directly to Gadi Saarony, Advarra CEO. Shough will be responsible for managing Advarra’s technology business segment, driving product strategy and offerings, commercialization, and customer relationships.

onathan E. Shough

“As we continue to evolve our technology offerings to empower sites and build connections across the clinical research ecosystem, Jonathan is a perfect fit to lead our efforts, and we’re pleased to welcome him to Advarra,” commented Saarony. “His proven expertise in developing and commercializing innovative technology solutions to improve the drug development process will further cement our position as the leader in practice management systems for clinical research and the preferred site technology partner for sponsors and CROs.”

Most recently, Shough was Senior Vice President and CIO, LabCorp Drug Development and GM Software Platforms, where he managed a large data and technology team and worked on several successful mergers and acquisitions. Prior to that, he held the position of Senior Vice President and Chief Data Officer at Syneos Health where he was responsible for developing and executing the data and commercialization strategy. At IQVIA, Shough served as executive director, IT, where he developed the technology go-to-market strategy and supported technology development. Earlier in his career, he held numerous information technology leadership positions in the financial and telecommunications industries. Shough attended Guilford College and is a US Marine Corps veteran.

“I am passionate about bringing the power of technology to improve the drug development process,” Shough said. “I’m excited to join Advarra and help progress their strategic vision to connect sites, CROs, and sponsors through technology.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”